Compare ARDX & GDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARDX | GDRX |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2014 | 2020 |
| Metric | ARDX | GDRX |
|---|---|---|
| Price | $4.05 | $3.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $15.14 | $3.66 |
| AVG Volume (30 Days) | ★ 2.6M | 1.2M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.00 |
| EPS | N/A | ★ 0.03 |
| Revenue | $2,607,000.00 | ★ $796,853,000.00 |
| Revenue This Year | $37.75 | N/A |
| Revenue Next Year | $34.24 | $5.38 |
| P/E Ratio | ★ N/A | $124.00 |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $4.71 | $1.77 |
| 52 Week High | $8.40 | $5.61 |
| Indicator | ARDX | GDRX |
|---|---|---|
| Relative Strength Index (RSI) | 34.44 | 73.11 |
| Support Level | N/A | $2.54 |
| Resistance Level | $6.47 | N/A |
| Average True Range (ATR) | 0.16 | 0.18 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 12.09 | 89.90 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.